Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1244277.RAw_TGecfI-bNhEut9ObW0DIw5vrZ4t66OKHMYifSwLWw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1244277.RAw_TGecfI-bNhEut9ObW0DIw5vrZ4t66OKHMYifSwLWw130_assertion type Assertion NP1244277.RAw_TGecfI-bNhEut9ObW0DIw5vrZ4t66OKHMYifSwLWw130_head.
- NP1244277.RAw_TGecfI-bNhEut9ObW0DIw5vrZ4t66OKHMYifSwLWw130_assertion description "[Persistent production of IFN-?, the most abundant subtype measured in these patients, is an important feature of the immunopathogenesis of lupus and has stimulated current efforts to develop and test therapeutics that either block IFN-I or its receptor directly or target components of the IFN-I pathway involved in induction of or response to IFN-I.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244277.RAw_TGecfI-bNhEut9ObW0DIw5vrZ4t66OKHMYifSwLWw130_provenance.
- NP1244277.RAw_TGecfI-bNhEut9ObW0DIw5vrZ4t66OKHMYifSwLWw130_assertion evidence source_evidence_literature NP1244277.RAw_TGecfI-bNhEut9ObW0DIw5vrZ4t66OKHMYifSwLWw130_provenance.
- NP1244277.RAw_TGecfI-bNhEut9ObW0DIw5vrZ4t66OKHMYifSwLWw130_assertion SIO_000772 25468480 NP1244277.RAw_TGecfI-bNhEut9ObW0DIw5vrZ4t66OKHMYifSwLWw130_provenance.
- NP1244277.RAw_TGecfI-bNhEut9ObW0DIw5vrZ4t66OKHMYifSwLWw130_assertion wasDerivedFrom befree-2016 NP1244277.RAw_TGecfI-bNhEut9ObW0DIw5vrZ4t66OKHMYifSwLWw130_provenance.
- NP1244277.RAw_TGecfI-bNhEut9ObW0DIw5vrZ4t66OKHMYifSwLWw130_assertion wasGeneratedBy ECO_0000203 NP1244277.RAw_TGecfI-bNhEut9ObW0DIw5vrZ4t66OKHMYifSwLWw130_provenance.